Companies: 10,638     total market cap: $135.472 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Ultragenyx Pharmaceutical
RARE
#3663
Rank
$3.50 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
$36.38
Share price
-0.44%
Change (1 day)
-26.33%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2025 (TTM): -$5.94

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$5.94. In 2024 the company made an earnings per share (EPS) of -$6.34 an increase over its 2023 EPS that were of -$8.33.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$5.94-6.31%
2024-$6.34-23.89%
2023-$8.33-17.61%
2022-$10.1150.67%
2021-$6.71113.69%
2020-$3.14-55.9%
2019-$7.1282.56%
2018-$3.90-45.15%
2017-$7.1114.68%
2016-$6.20
2014-$2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioMarin Pharmaceutical
BMRN
$2.72-145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-$0.11-98.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.54-90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-$0.19-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com